PCV117 Clinical and Patient-Reported Outcomes of Triple Combination of Olmesartan Medoxomil (OM), Amlodipine Besylate (AML) and Hydrochlorothiazide (HCT) in Hypertensive Patients
Abstract
Authors
B. Ehlken V. Claus R. Shlaen A.M.S. Oberdiek